| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Amsacrine |
| Brand | Amsidine® |
| Indication | For the induction and maintenance of remission in acute leukaemia of adults. |
| Assessment Process | |
| Rapid review commissioned | 10/01/2017 |
| Rapid review completed | 15/02/2017 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |